Trilaciclib: A First-in-class Therapy to Reduce Chemotherapy-induced Myelosuppression.
Autor: | Young, Joanna A.1, Tan, Antoinette R.2 Antoinette.Tan@atriumhealth.org |
---|---|
Zdroj: | touchREVIEWS in Oncology & Haematology. 2022, Vol. 18 Issue 2, p152-158. 7p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |